Inter-observer agreement using the LI-RADS version 2018 CT treatment response algorithm in patients with hepatocellular carcinoma treated with conventional transarterial chemoembolization

被引:8
|
作者
Bartnik, Krzysztof [1 ,2 ]
Podgorska, Joanna [2 ]
Rosiak, Grzegorz [2 ]
Korzeniowski, Krzysztof [2 ]
Rowinski, Olgierd [2 ]
机构
[1] Med Univ Warsaw, Doctoral Sch, Warsaw, Poland
[2] Med Univ Warsaw, Dept Radiol 2, Ul Banacha 1a, PL-02097 Warsaw, Poland
关键词
TACE; Hepatocellular carcinoma; LI-RADS treatment response; CT; CRITERIA;
D O I
10.1007/s00261-021-03272-9
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Aim To determine inter-reader agreement in categorization of imaging features using the Liver Imaging Reporting and Data System (LI-RADS) treatment response (LR-TR) algorithm in patients with hepatocellular carcinoma (HCC) treated with conventional transarterial chemoembolization (cTACE). Methods Two radiologists used the LR-TR algorithm to assess 112 computed tomography (CT) examinations of 102 patients treated with cTACE. The inter-observer agreement in categorization of LR-TR features was assessed using kappa (kappa) statistics. Results There was substantial inter-observer agreement between the two reviewers using the LR-TR algorithm (kappa = 0.70; 95% CI 0.58-0.81). The two reviewers categorized tumors as non-viable in 37 (33.0%) and 39 (34.8%) of 112 examinations, viable in 58 (51.8%) and 62 (55.4%) examinations, and equivocal in 18 (16.1%) and 11 (9.8%) examinations, respectively. There was almost perfect inter-observer agreement for the LR-TR non-viable category (kappa = 0.80; 95% CI 0.68-0.92), substantial agreement for the viable category (kappa = 0.78 95% CI 0.67-0.90), and fair agreement for the equivocal category (kappa = 0.25; 95% CI 0.02-0.49). Conclusion The LR-TR algorithm conveys high degrees of inter-observer agreement for the assessment of CT imaging features in the viable and non-viable categories. Further refinement of indeterminate features may be necessary to improve the correct categorization of equivocal lesions.
引用
收藏
页码:115 / 122
页数:8
相关论文
共 50 条
  • [41] Preoperative estimation of the survival of patients with unresectable hepatocellular carcinoma achieving complete response after conventional transcatheter arterial chemoembolization: assessments of clinical and LI-RADS MR features
    Wenlong Song
    Qianyu Chen
    Dajing Guo
    Caiming Jiang
    La radiologia medica, 2022, 127 : 939 - 949
  • [42] Hepatocellular Carcinoma Assessment after Locoregional Treatment: A Primer on LI-RADS Contrast-Enhanced Nonradiation Treatment Response Assessment Version 2024
    Milot, Laurent
    RADIOLOGY, 2024, 311 (02)
  • [43] Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics
    Kim, Jonghoon
    Choi, Seung Joon
    Lee, Seung-Hak
    Lee, Ho Yun
    Park, Hyunjin
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (05) : 1026 - 1034
  • [44] Incorporation of Ancillary MRI Features Into the LI-RADS Treatment Response Algorithm: Impact on Diagnostic Performance After Locoregional Treatment of Hepatocellular Carcinoma
    Kim, Yeun-Yoon
    Kim, Myeong-Jin
    Yoon, Ja Kyung
    Shin, Jaeseung
    Roh, Yun Ho
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2022, 218 (03) : 484 - 493
  • [45] Diagnostic performance of LI-RADS version 2018 in differentiating hepatocellular carcinoma from other hepatic malignancies in patients with hepatitis B virus infection
    Shao, Shuo
    Liang, Yingying
    Kuang, Sichi
    Chen, Jingbiao
    Shan, Qungang
    Yang, Hao
    Zhang, Yao
    Wang, Bin
    Fowler, Kathryn J.
    Wang, Jin
    Sirlin, Claude B.
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2020, 20 (03) : 401 - 410
  • [46] An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma
    Zhang, Lu
    Jin, Zhe
    Li, Chen
    He, Zicong
    Zhang, Bin
    Chen, Qiuying
    You, Jingjing
    Ma, Xiao
    Shen, Hui
    Wang, Fei
    Wu, Lingeng
    Ma, Cunwen
    Zhang, Shuixing
    RADIOLOGIA MEDICA, 2024, 129 (03): : 353 - 367
  • [47] An interpretable machine learning model based on contrast-enhanced CT parameters for predicting treatment response to conventional transarterial chemoembolization in patients with hepatocellular carcinoma
    Lu Zhang
    Zhe Jin
    Chen Li
    Zicong He
    Bin Zhang
    Qiuying Chen
    Jingjing You
    Xiao Ma
    Hui Shen
    Fei Wang
    Lingeng Wu
    Cunwen Ma
    Shuixing Zhang
    La radiologia medica, 2024, 129 : 353 - 367
  • [48] Performance of initial LI-RADS 2018 treatment response in predicting survival of patients with hepatocellular carcinoma following TACE: a retrospective, single-center cohort study
    Bartnik, Krzysztof
    Podgorska, Joanna
    Rosiak, Grzegorz
    Korzeniowski, Krzysztof
    Gizinski, Jakub
    Sajdek, Michal
    Wroblewski, Tadeusz
    Zieniewicz, Krzysztof
    Nyckowski, Pawel
    Rowinski, Olgierd
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2021, 147 (12) : 3673 - 3683
  • [49] Performance of initial LI-RADS 2018 treatment response in predicting survival of patients with hepatocellular carcinoma following TACE: a retrospective, single-center cohort study
    Krzysztof Bartnik
    Joanna Podgórska
    Grzegorz Rosiak
    Krzysztof Korzeniowski
    Jakub Giziński
    Michał Sajdek
    Tadeusz Wróblewski
    Krzysztof Zieniewicz
    Paweł Nyckowski
    Olgierd Rowiński
    Journal of Cancer Research and Clinical Oncology, 2021, 147 : 3673 - 3683
  • [50] Comprehensive predictive factors for CalliSpheres® microspheres (CSM) drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization on treatment response and survival in hepatocellular carcinoma patients
    Chen, Changyong
    Qiu, Huaiming
    Yao, Yuanhui
    Zhang, Zishu
    Ma, Cong
    Ma, Yilong
    Zhao, Chang
    Xiang, Hua
    Zhao, Hui
    Zheng, Chuansheng
    Xiong, Bin
    Li, Haiping
    Long, Qingyun
    Zhou, Jun
    Luo, Chao
    Hu, Hongyao
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2021, 45 (02)